Correlation Between Ventyx Biosciences and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Larimar Therapeutics, you can compare the effects of market volatilities on Ventyx Biosciences and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Larimar Therapeutics.
Diversification Opportunities for Ventyx Biosciences and Larimar Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Ventyx and Larimar is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Larimar Therapeutics
Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Larimar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Ventyx Biosciences is 1.88 times less risky than Larimar Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Larimar Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 735.00 in Larimar Therapeutics on August 24, 2024 and sell it today you would lose (122.00) from holding Larimar Therapeutics or give up 16.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ventyx Biosciences vs. Larimar Therapeutics
Performance |
| Timeline |
| Ventyx Biosciences |
| Larimar Therapeutics |
Ventyx Biosciences and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Larimar Therapeutics
The main advantage of trading using opposite Ventyx Biosciences and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |